Literature DB >> 8298140

Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils.

L Kjeldsen1, D F Bainton, H Sengeløv, N Borregaard.   

Abstract

Neutrophil gelatinase-associated lipocalin (NGAL) is a novel 25-kD protein of human neutrophils, that is in part covalently complexed with neutrophil gelatinase. However, both NGAL and gelatinase exist mainly in forms not associated with each other. An explanation for this phenomenon might be that the unassociated proteins reside in different subcellular compartments. The aim of the present study was to determine the subcellular localization of NGAL. An enzyme-linked immunosorbent assay (ELISA) for NGAL was developed using specific anti-NGAL antibodies. The assay was applied on subcellular fractions of neutrophils obtained after centrifugation of a postnuclear supernatant on a two-layer Percoll gradient. The distribution profile of NGAL was found to colocalize strictly with the distribution profile of lactoferrin. This was confirmed by immunogold double-labeling of frozen thin sections of neutrophils that showed a high degree of colocalization of NGAL and lactoferrin, and by exocytosis experiments, which showed lactoferrin, vitamin B12-binding protein, and NGAL to be similarly released upon stimulation. Therefore, NGAL is a novel matrix protein of specific granules and thus partly segregated from gelatinase, the major part of which is located in a separate compartment, the gelatinase granules. An ELISA specific for the NGAL/gelatinase complex was developed and the subcellular distribution and release of this complex was determined. The distribution and mobilization of the complex allowed us to confirm the existence of differentially mobilized granule subpopulations among peroxidase negative granules.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8298140

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  110 in total

1.  Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection.

Authors:  Magnus Steigedal; Anne Marstad; Markus Haug; Jan K Damås; Roland K Strong; Pacita L Roberts; Stephanie D Himpsl; Ann Stapleton; Thomas M Hooton; Harry L T Mobley; Thomas R Hawn; Trude H Flo
Journal:  J Immunol       Date:  2014-11-14       Impact factor: 5.422

2.  Intractable diarrhoea of infancy caused by neutrophil specific granule deficiency and cured by stem cell transplantation.

Authors:  R F Wynn; M Sood; K Theilgaard-Mönch; C J Jones; A F Gombart; M Gharib; H P Koeffler; N Borregaard; P D Arkwright
Journal:  Gut       Date:  2006-02       Impact factor: 23.059

3.  Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer.

Authors:  Zhimin Tong; Ajaikumar B Kunnumakkara; Huamin Wang; Yoichi Matsuo; Parmeswaran Diagaradjane; Kuzhuvelil B Harikumar; Vijaya Ramachandran; Bokyung Sung; Arup Chakraborty; Robert S Bresalier; Craig Logsdon; Bharat B Aggarwal; Sunil Krishnan; Sushovan Guha
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

4.  Targeting of proteins to granule subsets is determined by timing and not by sorting: The specific granule protein NGAL is localized to azurophil granules when expressed in HL-60 cells.

Authors:  V Le Cabec; J B Cowland; J Calafat; N Borregaard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

5.  Circulating levels of neutrophil gelatinase-associated lipocalin (NGAL) correlate with the presence and severity of preeclampsia.

Authors:  Sun Min Kim; Joong Shin Park; Errol R Norwitz; Hee Jung Jung; Byoung Jae Kim; Chan-Wook Park; Jong Kwan Jun
Journal:  Reprod Sci       Date:  2013-02-25       Impact factor: 3.060

6.  Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice.

Authors:  Hong Guo; Daozhong Jin; Yuanyuan Zhang; Wendy Wright; Merlijn Bazuine; David A Brockman; David A Bernlohr; Xiaoli Chen
Journal:  Diabetes       Date:  2010-03-23       Impact factor: 9.461

7.  Lipocalin 2 is protective against E. coli pneumonia.

Authors:  Hong Wu; Eric Santoni-Rugiu; Elisabeth Ralfkiaer; Bo T Porse; Claus Moser; Niels Høiby; Niels Borregaard; Jack B Cowland
Journal:  Respir Res       Date:  2010-07-15

8.  The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages.

Authors:  Jinhui Zhang; Yingjie Wu; Yuanyuan Zhang; Derek Leroith; David A Bernlohr; Xiaoli Chen
Journal:  Mol Endocrinol       Date:  2008-02-21

9.  Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin.

Authors:  Michael A Bachman; Virginia L Miller; Jeffrey N Weiser
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823

Review 10.  Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin.

Authors:  Eduardo Esteve; Wifredo Ricart; José Manuel Fernández-Real
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.